Baicalin Attenuates High Fat Diet-Induced Obesity and Liver Dysfunction: Dose-Response and Potential Role of CaMKKβ/AMPK/ACC Pathway | Zendy

Youli Xi | Zendy; Miaozong Wu | Zendy; Hongxia Li | Zendy; Siqi Dong | Zendy; Erfei Luo | Zendy; Mingbo Gu | Zendy; Xiao Z. Shen | Zendy; Yabo Jiang | Zendy; Yaqun Liu | Zendy; Hua Liu | Zendy

Open Access

Baicalin Attenuates High Fat Diet-Induced Obesity and Liver Dysfunction: Dose-Response and Potential Role of CaMKKβ/AMPK/ACC Pathway

Author(s) -

Youli Xi,

Miaozong Wu,

Hongxia Li,

Siqi Dong,

Erfei Luo,

Mingbo Gu,

Xiao Z. Shen,

Yabo Jiang,

Yaqun Liu,

Hua Liu

Publication year - 2015

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000374037

Subject(s) - baicalin , ampk , fatty liver , endocrinology , medicine , steatosis , hyperlipidemia , alanine transaminase , aspartate transaminase , liver function , protein kinase a , chemistry , kinase , diabetes mellitus , biochemistry , enzyme , alkaline phosphatase , disease , high performance liquid chromatography , chromatography

Obesity-associated fatty liver disease affects millions of individuals. This study aimed to evaluate the therapeutic effects of baicalin to treat obesity and fatty liver in high fat diet-induced obese mice, and to study the potential molecular mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research